Primera Therapeutics focuses on developing gene editing therapies targeting mitochondrial DNA mutations, addressing the root cause of mitochondrial diseases, which can lead to severe childhood diseases, chronic kidney disease, and metabolic disorders.
Create a free account to see more
Free members can view HQ location, employee count, capabilities, year founded, funding stage, and more.
Premium members only
Upgrade to Premium to view key contacts including name, title, and verified email.